Termination Pursuant to Section 8. 2. (a) In the event of termination of this Agreement in its entirety by Pfizer under Section 8.2, the Research Program Term shall terminate and all rights and licenses granted by Arvinas to Pfizer under Article 3 shall be terminated and all relevant rights shall revert to Arvinas. (b) In the event of partial termination of this Agreement by Pfizer under Section 8.2 with respect to any Target, all rights and licenses granted by Arvinas to Pfizer under Article 3 with respect to the relevant Target and related Compounds and Products shall be terminated and all relevant rights shall revert to Arvinas, and any exclusivity pursuant to Section 2.10 with respect to the relevant Target shall terminate.
Appears in 3 contracts
Sources: Research Collaboration and License Agreement (Arvinas Holding Company, LLC), Research Collaboration and License Agreement (Arvinas Holding Company, LLC), Research Collaboration and License Agreement (Arvinas Holding Company, LLC)